Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company#39;s revenue from operations in FY22
Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company#39;s revenue from operations in FY22 Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company#39;s revenue from operations in FY22 Moneycontrol Latest News Read More